C

Cengild Medical Bhd
KLSE:CENGILD

Watchlist Manager
Cengild Medical Bhd
KLSE:CENGILD
Watchlist
Price: 0.285 MYR 1.79% Market Closed
Market Cap: 237.4m MYR
Have any thoughts about
Cengild Medical Bhd?
Write Note
Section:
 

Relative Value

The Relative Value of one CENGILD stock under the Base Case scenario is 0.208 MYR. Compared to the current market price of 0.285 MYR, Cengild Medical Bhd is Overvalued by 27%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CENGILD Relative Value
Base Case
0.208 MYR
Overvaluation 27%
Relative Value
Price
C
Worst Case
Base Case
Best Case

Valuation Multiples

3.3
P/S
P/S
Price to Sales
3.3
vs History
79
vs Industry
33
Median 3Y
4
Median 5Y
4
Industry
2.3
More Details
N/A
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
27
Median 3Y
22.6
Median 5Y
22.6
Industry
23.1
More Details
17.2
P/OCF
P/OCF
Price to OCF
17.2
vs History
67
vs Industry
21
Median 3Y
19.6
Median 5Y
19.6
Industry
14.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
21
Median 3Y
24
Median 5Y
24
Industry
20.1
More Details
2.1
P/B
P/B
Price to Book Value
2.1
vs History
79
vs Industry
38
Median 3Y
2.9
Median 5Y
2.9
Industry
2.2
More Details
2.1
EV/S
EV/S
Enterprise Value to Sales
2.1
vs History
79
vs Industry
45
Median 3Y
2.7
Median 5Y
2.7
Industry
2.4
More Details
4.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.5
vs History
79
vs Industry
41
Median 3Y
5.9
Median 5Y
5.9
Industry
5
More Details
31.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
31.1
vs History
0
vs Industry
38
Median 3Y
10.7
Median 5Y
10.7
Industry
12.7
More Details
N/A
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
38
Median 3Y
10.9
Median 5Y
10.9
Industry
17.1
More Details
10.8
EV/OCF
EV/OCF
Enterprise Value to OCF
10.8
vs History
67
vs Industry
32
Median 3Y
13.6
Median 5Y
13.6
Industry
14
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
28
Median 3Y
12.6
Median 5Y
12.6
Industry
18
More Details
3.5
EV/IC
EV/IC
Enterprise Value to IC
3.5
vs History
85
vs Industry
17
Median 3Y
7.1
Median 5Y
7.1
Industry
1.9
More Details

Multiples Across Competitors

CENGILD Competitors Multiples
Cengild Medical Bhd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
MY
Cengild Medical Bhd
KLSE:CENGILD
237.4m MYR 3.3 0 31.1 0
US
HCA Healthcare Inc
NYSE:HCA
78.1B USD 1.1 13.2 8.3 10.8
SA
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
98B SAR 9.3 44 39 45.3
ZA
Life Healthcare Group Holdings Ltd
JSE:LHC
24.1B Zac 0 0 0 0
ZA
Netcare Ltd
JSE:NTC
20B Zac 0 0 0 0
CN
Aier Eye Hospital Group Co Ltd
SZSE:300015
129.8B CNY 6.3 35.8 27 27
MY
IHH Healthcare Bhd
KLSE:IHH
63.8B MYR 2.8 24.1 13 18.8
IN
Max Healthcare Institute Ltd
NSE:MAXHEALTH
1.1T INR 19.4 105 73 87.1
IN
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
1T INR 5.3 100.7 41.9 57.4
US
Tenet Healthcare Corp
NYSE:THC
12.2B USD 0.6 3.9 5.2 6.5
US
Universal Health Services Inc
NYSE:UHS
11.9B USD 0.8 11.6 7.7 10.7

See Also

Summary
CENGILD intrinsic value, competitors valuation, and company profile.
DCF Valuation
CENGILD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CENGILD stock valuation using valuation multiples.
Wall Street Estimates
CENGILD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CENGILD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.